Clinicaltrials.gov identifier:
NCT02206360
Study Contact Information:
Jessica Maldonado, NP
Phone Number: 914-849-2530
Email: [email protected]
or
Joshua P Raff, MD
Phone Number: 914-849-7600
Email: [email protected]
Pancreatic Cancer Early Detection Program
About the Study
NOTE: This study is no longer recruiting patients.
This is a study looking at esophageal as a screening for pancreatic cancer in high risk individuals. The study will enroll people with an inherited risk for cancer due to a or CDKN2A mutation with or without a family history of pancreatic cancer. The study will also enroll people with a first- or with pancreatic cancer with (, , , , ) or any of the following mutations , P53, , APC, or .
What the Study Entails
Enrolled subjects will undergo Endoscopic (EUS) alternating with Magnetic Resonance Imaging (), every six to 12 months, for up to 5 years.
Study Lead Investigator
Principal Investigator: Joshua P Raff, MD
NOTE: This study is no longer recruiting patients.
NOTE: This study is no longer recruiting patients.